The #1 Cannabis Risk That No One Is Talking About

The cannabis industry is facing a ton of hype, but one major risk remains that could threaten every pot stock on the market.

| More on:
Road sign warning of a risk ahead

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The cannabis industry hit its stride last year, with many pot stocks rising by 100% or more. In many ways, the exuberance is warranted.

In 2018, Canada became the first industrialized country in the world to legalize recreational cannabis. Many U.S. states followed suit. Today, most states in the U.S. have some form of legal marijuana, even if it’s not available to everyone on a recreational basis.

Over the last 12 months the tides have turned abruptly, catapulting marijuana into a legitimate industry. More recently, Wall Street analysts have fueled the fire with hard numbers.

After garnering less than US$7 billion in global sales in 2016, the cannabis market surpassed US$12 billion in sales last year.

By 2022, Arcview Market Research anticipates the market will reach $31.3 billion. Cowen Inc believes that the market could reach $50 billion in global sales by 2026, ballooning further to $75 billion by 2030.

Clearly, cannabis is set to become a major growth story for at least a decade. However, amid the hype, many investors are ignoring some real risks that could ultimately bring down many pot stocks.

If you’re investing in the cannabis industry, you’ll want to fully understand the biggest risk nearly every marijuana producer will face: commoditization.

Growth at a steep cost

At the end of the day, cannabis companies are simply growing crops. The planting and harvesting cycle isn’t too different from corn, tomatoes, or soybean. Take Village Farms International Inc (TSX:VFF)(NASDAQ:VFF) for example.

For more than a decade, Village Farms simply grew produce, like peppers and cucumbers. From 2010 to 2016, when the company was solely focused on vegetables, the stock price went nowhere, never breaching the $1 per share mark.

After it pivoted to cannabis, the stock price jumped from $0.80 apiece to more than $18 each.

Even Village Farms admits that growing marijuana won’t be too difficult. Management has repeatedly said that its expertise in growing vegetables makes the company a plug-and-play producer of cannabis.

In the coming months, Village Farms will have more than one million square feet of cannabis production capacity. By the summer of this year, it should hit run-rate cannabis production of 75,000 kilograms.

Village Farms has become a cannabis powerhouse virtually overnight, with a market valuation approaching $1 billion. But the company’s success proves that growing cannabis isn’t that difficult. Check out the list below: nearly any supplier can do it.

Cronos Group Inc is on track for more than 100,000 kilograms in annual output.

Aphria Inc is targeting 115,000 kilograms annually, up from 30,000 kilograms this year.

Green Organic Dutchman Holdings Ltd wants to grow 65,000 kilograms of cannabis this year, up from nearly nothing the year before.

Aurora Cannabis Inc is on its way to producing a staggering 700,000 kilograms over the next few years.

While there are some regulatory barriers to growing cannabis, some fail to appreciate that commercial vegetable growers must also jump through large amounts of red tape. If there truly are great profits to be had, expect more and more producers to jump into the market.

Today, it’s not very profitable to grow staples like tomatoes, beans, rice, or cabbage. In another decade, there’s a chance that growing cannabis isn’t wildly profitable either. That reality could crush nearly every cannabis stock.

Commoditization could be a lot closer than you think. In late 2018, news outlets reported that Oregon was “drowning in one million pounds of excess weed.” That’s a scary headline for any cannabis investor.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »